Get the latest Science News and Discoveries

Landmark Nature Medicine study reports promising new treatment reduces suffering in Sanfilippo syndrome - EurekAlert


As a neurodegenerative disease characterized by childhood onset dementia, Sanfilippo syndrome causes immense suffering in many ways, including pain, loss of speech, extreme agitation, and distress, gastrointestinal symptoms, and profound sleep disturbance. With no approved treatment, clinical specialists have had few options to help alleviate this suffering until now. A groundbreaking clinical trial collaboration between study lead and principal investigator Lynda Polgreen, MD, MS, Investigator at The Lundquist Institute for Biomedical Innovation at Harbor-UCLA (TLI) and Associate Professor of Pediatrics at the David Geffen School of Medicine at UCLA and Cure Sanfilippo Foundation’s Chief Science Officer and study co-investigator, Cara O’Neill, MD, FAAP, used an innovative approach to treat this disease by targeting neuroinflammation, as it is thought to be a key contributor to disease symptoms.

None

Get the Android app

Or read this on Eureka Alert

Read more on:

Photo of EurekAlert

EurekAlert

Photo of Sanfilippo syndrome

Sanfilippo syndrome

Photo of Sanfilippo

Sanfilippo

Related news:

News photo

First of its kind detection made in striking new Webb image - EurekAlert

News photo

Cooling 'blood oranges' could make them even healthier – a bonus for consumers - EurekAlert

News photo

Imaging technology captures how neurons communicate with new clarity - EurekAlert